Motion to Intervene AstraZeneca v. Cochran, Feb. 26, 2021, Re: 340B Contract Pharmacy Intervention

UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE

ASTRAZENECA PHARMACEUTICALS LP

                      Plaintiff,
                         –v–

NORRIS COCHRAN, et al.,
                                 
                   Defendants.

C.A. No. 21-00027 (LPS)

THE AMERICAN HOSPITAL ASSOCIATION, 340B HEALTH, AMERICA’S
ESSENTIAL HOSPITALS, THE ASSOCIATION OF AMERICAN MEDICAL
COLLEGES, THE CHILDREN’S HOSPITAL ASSOCIATION, AND
THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACIST’S
MOTION TO INTERVENE

The American Hospital Association, 340B Health, America’s Essential Hospitals, the Association of American Medical Colleges, National Association of Children’s Hospitals d/b/a the Children’s Hospital Association, and American Society of Health-System Pharmacists (collectively the “Proposed Intervenors”) move this Court, pursuant to Federal Rule of Civil Procedure 24(a) or in the alternative pursuant to Federal Rule of Civil Procedure 24(b), for an Order granting their Motion to Intervene in this lawsuit regarding the 340B Drug Discount Program.

In support of this motion, Proposed Intervenors are submitting Exhibits A through N and a proposed order. In accordance with D. Del. L.R. 7.1.1, Proposed Intervenors consulted with counsel for Plaintiff and Defendants. Plaintiff and Defendants oppose the Motion to Intervene.

View the entire document under Key Resources.